IL2 and neoplasm: In this report, we constructed novel oncolytic rVACV strains to explore the anti-tumor effectiveness of TAAs-derived peptides and/or IL2 expressed by these virus strains in 4T1 tumor-bearing immunocompetent BALB/c mice.